Brief: Jacobio Pharmaceuticals Posts FY Loss Attributable Of RMB301.2 Million
22/03/2022 14:38
March 22 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd
1167.HK :
* FY LOSS ATTRIBUTABLE RMB301.2 MILLION VERSUS LOSS OF
RMB1.51
BILLION
* FY REVENUE RMB152.8 MILLION VERSUS RMB486.3 MILLION
Source text for Eikon: ID:nHKS45ctg6
Further company coverage: 1167.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan